Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 study of upadacitinib in adults and adolescents with non-segmental vitiligo
CTR20241696Phase 3Active
- Sponsor
- AbbVie Inc.
- Start
- Jun 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of upadacitinib in Vitiligo, sponsored by AbbVie Inc.. Started Jun 2024; status: active.
02
Drugs
upadacitinib
03
Conditions
Vitiligo
Beyond the preview
Go deeper on CTR20241696.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20241696.